Transmitted Virus Fitness and Host T Cell Responses Collectively Define Divergent Infection Outcomes in Two HIV-1 Recipients

Yue, Ling; Pfafferott, Katja J.; Baalwa, Joshua; Conrod, Karen; Dong, Catherine C.; Chui, Cecilia; Rong, Rong; Claiborne, Daniel T.; Prince, Jessica L.; Tang, Jianming; Ribeiro, Ruy M.; Cormier, Emmanuel; Hahn, Beatrice H.; Perelson, Alan S.; Shaw, George M.; Karita, Etienne; Gilmour, Jill; Goepfert, Paul; Derdeyn, Cynthia A.; Allen, Susan A.
January 2015
PLoS Pathogens;Jan2015, Vol. 11 Issue 1, p1
Academic Journal
Control of virus replication in HIV-1 infection is critical to delaying disease progression. While cellular immune responses are a key determinant of control, relatively little is known about the contribution of the infecting virus to this process. To gain insight into this interplay between virus and host in viral control, we conducted a detailed analysis of two heterosexual HIV-1 subtype A transmission pairs in which female recipients sharing three HLA class I alleles exhibited contrasting clinical outcomes: R880F controlled virus replication while R463F experienced high viral loads and rapid disease progression. Near full-length single genome amplification defined the infecting transmitted/founder (T/F) virus proteome and subsequent sequence evolution over the first year of infection for both acutely infected recipients. T/F virus replicative capacities were compared in vitro, while the development of the earliest cellular immune response was defined using autologous virus sequence-based peptides. The R880F T/F virus replicated significantly slower in vitro than that transmitted to R463F. While neutralizing antibody responses were similar in both subjects, during acute infection R880F mounted a broad T cell response, the most dominant components of which targeted epitopes from which escape was limited. In contrast, the primary HIV-specific T cell response in R463F was focused on just two epitopes, one of which rapidly escaped. This comprehensive study highlights both the importance of the contribution of the lower replication capacity of the transmitted/founder virus and an associated induction of a broad primary HIV-specific T cell response, which was not undermined by rapid epitope escape, to long-term viral control in HIV-1 infection. It underscores the importance of the earliest CD8 T cell response targeting regions of the virus proteome that cannot mutate without a high fitness cost, further emphasizing the need for vaccines that elicit a breadth of T cell responses to conserved viral epitopes.


Related Articles

  • Neglected Opportunities. Moench, Thomas R. // Journal of Infectious Diseases;2/1/2000, Vol. 181 Issue 2, p804 

    Comments on the study by Lavreys et al on a vaccination strategy that would reduced human immunodeficiency virus transmission, published in 'The Journal of Infectious Diseases.' Focus of HIV-prevention efforts; Use of male circumcision as a vaccination strategy; Probable reasons for the failure...

  • Differential Blood and Mucosal Immune Responses against an HIV-1 Vaccine Administered via Inguinal or Deltoid Injection. Yang, Otto O.; Ibarrondo, F. Javier; Price, Charles; Hultin, Lance E.; Elliott, Julie; Hultin, Patricia M.; Shih, Roger; Hausner, Mary Ann; Ng, Hwee L.; Hoffman, Jennifer; Jamieson, Beth D.; Anton, Peter A. // PLoS ONE;Feb2014, Vol. 9 Issue 2, p1 

    : Mucosal immunity is central to sexual transmission and overall pathogenesis of HIV-1 infection, but the ability of vaccines to induce immune responses in mucosal tissue compartments is poorly defined. Because macaque vaccine studies suggest that inguinal (versus limb) vaccination may better...

  • Pediatric vaccine trials limited in U.S.  // AIDS Patient Care & STDs;Apr96, Vol. 10 Issue 2, p134 

    Focuses on the clinical trials for vaccines to prevent AIDS mother-child transmission in the United States. Transmission rate; Comments from Ross McKinney, the clinical director of Duke University's AIDS Clinical Trial Unit.

  • HIV-1 gp41 envelope IgA is frequently elicited after transmission but has an initial short response half-life. Yates, N L; Stacey, A R; Nolen, T L; Vandergrift, N A; Moody, M A; Montefiori, D C; Weinhold, K J; Blattner, W A; Borrow, P; Shattock, R; Cohen, M S; Haynes, B F; Tomaras, G D // Mucosal Immunology (1933-0219);Jul2013, Vol. 6 Issue 4, p692 

    Prevention of HIV-1 transmission at mucosal surfaces will likely require durable pre-existing mucosal anti-HIV-1 antibodies (Abs). Defining the ontogeny, specificities and potentially protective nature of the initial mucosal virus-specific B-cell response will be critical for understanding how...

  • Viral Evolution and Escape during Acute HIV-1 Infection. Boutwell, Christian L.; Rolland, Morgane M.; Herbeck, Joshua T.; Mullins, James I.; Allen, Todd M. // Journal of Infectious Diseases;10/15/2010 Primary HIV-1 Infection, Vol. 202, pS309 

    The extensive genetic diversity of human immunodeficiency virus type 1 (HIV-1) presents a significant barrier to the development of an effective and durable HIV vaccine. This variability not only makes it difficult to identify the targets against which immune responses should be directed, but it...

  • Protection Versus Pathology in Aviremic and High Viral Load HIV-2 Infection—The Pivotal Role of Immune Activation and T-cell Kinetics. Hegedus, Andrea; Nyamweya, Samuel; Zhang, Yan; Govind, Sheila; Aspinall, Richard; Mashanova, Alla; Jansen, Vincent A. A.; Whittle, Hilton; Jaye, Assan; Flanagan, Katie L.; Macallan, Derek C. // Journal of Infectious Diseases;Sep2014, Vol. 210 Issue 5, p752 

    Background. Many human immunodeficiency virus (HIV)–2-infected individuals remain aviremic and behave as long-term non-progressors but some progress to AIDS. We hypothesized that immune activation and T-cell turnover would be critical determinants of non-progressor/progressor...

  • Modelling the Evolution and Spread of HIV Immune Escape Mutants.  // PLoS Pathogens;Nov2010, Vol. 6 Issue 11, p1 

    No abstract available.

  • Heterosexual and Homosexual Partners Practising Unprotected Sex May Develop Allogeneic Immunity and to a Lesser Extent Tolerance.  // PLoS ONE;2009, Vol. 4 Issue 11, p1 

    The article focuses on a study conducted to investigate into the development of allogeneic immunity and tolerance, to a lesser extent, in heterosexual and homosexual partners practising unprotected sex. In the study, allogeneic responses in homosexual and heterosexual couples practising...

  • Mucosal Transmission of HIV-1: First Stop Dendritic Cells. Wilkinson, John; Cunningham, Anthony L. // Current Drug Targets;Dec2006, Vol. 7 Issue 12, p1563 

    Worldwide the heterosexual route is the prevalent mode of transmission of HIV, increasing the demand for measures that block the sexual spread of HIV infection. Vaccines designed to prevent mucosal transmission of HIV should be considered a component of vaccine strategies against HIV (in...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics